Dietary modulation of inflammation-induced colorectal cancer through PPARγ

PPAR Research

Volumn , Issue , 2009, Pages

  Carter, Ashlee B ^a   Misyak, Sarah A ^a   Hontecillas, Raquel ^a   Bassaganya Riera, Josep ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; BLUEBERRY EXTRACT; CALCIUM; CONJUGATED LINOLEIC ACID; CURCUMIN; DOCOSAHEXAENOIC ACID; FOLIC ACID; GAMMA TOCOPHEROL; ICOSAPENTAENOIC ACID; KAEMPFEROL; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHYTOESTROGEN; PIOGLITAZONE; PREBIOTIC AGENT; PROBIOTIC AGENT; QUERCETIN; RESVERATROL; SYNBIOTIC AGENT; TROGLITAZONE; VITAMIN D;

ARTICLE; BREAST CANCER; CANCER PALLIATIVE THERAPY; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLITIS; COLON CANCER; COLORECTAL CANCER; COMPETITIVE INHIBITION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY FIBER; ENTERITIS; GINSENG; HEALTH CARE COST; HEART DISEASE; HUMAN; IMMUNOMODULATION; INFLAMMATION; LUNG CANCER; MUCOSAL IMMUNITY; MYELODYSPLASTIC SYNDROME; NEOPLASM; NONHUMAN; OSTEOPOROSIS; PANCREAS CANCER; PATHOGENESIS; PREVALENCE; PROSTATE CANCER; PSORIASIS; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SKIN CANCER; SKIN DISEASE;

EID: 70349121009     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2009/498352     Document Type: Article

References (92)

1. Atreya I., Neurath M. F., Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies Expert Review of Anticancer Therapy 2008 8 4 561 572
2. Xie J., Itzkowitz S. H., Cancer in inflammatory bowel disease World Journal of Gastroenterology 2008 14 3 378 389
3. Miller B. A., Chu K. C., Hankey B. F., Ries L. A. G., Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S Cancer Causes Control 2008 19 3 227 256
4. Ries L. A., Melbert D., Krapcho M., SEER cancer statistics review, 19752005 Annual Report 2008 Bethesda, Md, USA National Cancer Institute
5. Spunt S., Furman W., La Quaglia M., Bondy M., Goldberg R., Cancer epidemiology in older adolescents and young adults 15 to 29 years of age SEER AYA Monograph 2006 Bethesda, Md, USA National Cancer Institute
6. Zisman T. L., Rubin D. T., Colorectal cancer and dysplasia in inflammatory bowel disease World Journal of Gastroenterology 2008 14 17 2662 2669
7. Greicius G., Arulampalam V., Pettersson S., A CLAs act: feeding away inflammation Gastroenterology 2004 127 3 994 996 (Pubitemid 39208433)
8. Savage D. C., Microbial ecology of the gastrointestinal tract Annual Review of Microbiology 1977 31 107 133
9. Chow J., Mazmanian S. K., Getting the bugs out of the immune system: do bacterial microbiota fix intestinal T cell responses? Cell Host Microbe 2009 5 1 8 12
10. Ferguson L. R., Philpott M., Cancer prevention by dietary bioactive components that target the immune response Current Cancer Drug Targets 2007 7 5 459 464 (Pubitemid 47196205)
11. Olefsky J. M., Nuclear receptor minireview series The Journal of Biological Chemistry 2001 276 40 36863 36864 (Pubitemid 37384092)
12. Chow E. K.-H., Razani B., Cheng G., Innate immune system regulation of nuclear hormone receptors in metabolic diseases Journal of Leukocyte Biology 2007 82 2 187 195 (Pubitemid 47230626)
13. Overington J. P., Al-Lazikani B., Hopkins A. L., How many drug targets are there? Nature Reviews Drug Discovery 2006 5 12 993 996
14. McFarland L. V., State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008 World Journal of Gastroenterology 2008 14 17 2625 2629
15. Lakatos P. L., Lakatos L., Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies World Journal of Gastroenterology 2008 14 25 3937 3947
16. Read J. A., Choy S. T. B., Beale P. J., Clarke S. J., Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival Nutrition and Cancer 2006 55 1 78 85 (Pubitemid 44477048)
17. Murphy K., Travers P., Walport M., Janeways Immunobiology 2008 7th New York, NY, USA Garland Science, Taylor Francis, LLC
18. Okamoto K., Fukatsu K., Ueno C., T lymphocyte numbers in human gut associated lymphoid tissue are reduced without enteral nutrition Journal of Parenteral and Enteral Nutrition 2005 29 1 56 58
19. Shoelson S. E., Lee J., Goldfine A. B., Inflammation and insulin resistance The Journal of Clinical Investigation 2006 116 7 1793 1801 (Pubitemid 44033299)
20. Crohn B. B., Ginzburg L., Oppenhaimer G. D., Regional ileitis, a pathologic and clinical entity The Journal of the American Medical Association 1932 99 6 1323 1329 (Pubitemid 14212889)
21. Bassaganya-Riera J., Ferrer G., Casagran O., F 4 / 80 hi CCR 2 hi macrophage infiltration into the intra-abdominal fat worsens the severity of experimental IBD in obese mice with DSS colitis e-SPEN 2009 4 2 e90 e97
22. Moghaddam A. A., Woodward M., Huxley R., Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events Cancer Epidemiology Biomarkers Prevention 2007 16 12 2533 2547
23. Szles L., Trcsik D., Nagy L., PPAR in immunity and inflammation: cell types and diseases Biochimica et Biophysica Acta 2007 1771 8 1014 1030 (Pubitemid 47202035)
24. Munkholm P., Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease Alimentary Pharmacology Therapeutics 2003 18 supplement 2 1 5 (Pubitemid 37174709)
25. Blay J.-Y., Negrier S., Combaret V., Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma Cancer Research 1992 52 12 3317 3322
26. Desreumaux P., Ghosh S., Review article: mode of action and delivery of 5-aminosalicylic acidnew evidence Alimentary Pharmacology Therapeutics 2006 24 supplement 1 2 9 (Pubitemid 44267773)
27. Chen L.-W., Egan L., Li Z.-W., Greten F. R., Kagnoff M. F., Karin M., The two faces of IKK and NF- B inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion Nature Medicine 2003 9 5 575 581 (Pubitemid 36597104)
28. Naugler W. E., Karin M., NF- B and canceridentifying targets and mechanisms Current Opinion in Genetics Development 2008 18 1 19 26
29. Rakoff-Nahoum S., Medzhitov R., Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88 Science 2007 317 5834 124 127 (Pubitemid 47056471)
30. Naugler W. E., Sakurai T., Kim S., Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 2007 317 5834 121 124 (Pubitemid 47056470)
31. Balkwill F., TNF- in promotion and progression of cancer Cancer and Metastasis Reviews 2006 25 3 409 416
32. Greten F. R., Eckmann L., Greten T. F., IKK links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 2004 118 3 285 296 (Pubitemid 39061110)
33. Popivanova B. K., Kitamura K., Wu Y., Blocking TNF- in mice reduces colorectal carcinogenesis associated with chronic colitis The Journal of Clinical Investigation 2008 118 2 560 570
34. Kim S., Keku T. O., Martin C., Circulating levels of inflammatory cytokines and risk of colorectal adenomas Cancer Research 2008 68 1 323 328
35. Warburg O., On the origin of cancer cells Science 1956 123 3191 309 314
36. Pelicano H., Carney D., Huang P., ROS stress in cancer cells and therapeutic implications Drug Resistance Updates 2004 7 2 97 110 (Pubitemid 38736063)
37. Roessner A., Kuester D., Malfertheiner P., Schneider-Stock R., Oxidative stress in ulcerative colitis-associated carcinogenesis Pathology Research and Practice 2008 204 7 511 524
38. Thompson E. A., PPAR physiology and pathology in gastrointestinal epithelial cells Molecules and Cells 2007 24 2 167 176 (Pubitemid 350177175)
39. Kostadinova R., Wahli W., Michalik L., PPARs in diseases: control mechanisms of inflammation Current Medicinal Chemistry 2005 12 25 2995 3009 (Pubitemid 41672488)
40. Lefebvre M., Paulweber B., Fajas L., Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells Journal of Endocrinology 1999 162 3 331 340 (Pubitemid 29447426)
41. Saez E., Tontonoz P., Nelson M. C., Activators of the nuclear receptor PPAR enhance colon polyp formation Nature Medicine 1998 4 9 1058 1061 (Pubitemid 28417339)
42. Sarraf P., Mueller E., Smith W. M., Loss-of-function mutations in PPAR associated with human colon cancer Molecular Cell 1999 3 6 799 804 (Pubitemid 29323058)
43. Voutsadakis I. A., Peroxisome proliferator-activated receptor (PPAR ) and colorectal carcinogenesis Journal of Cancer Research and Clinical Oncology 2007 133 12 917 928 (Pubitemid 47561718)
44. Koeffler H. P., Peroxisome proliferator-activated receptor and cancers Clinical Cancer Research 2003 9 1 1 9 (Pubitemid 36109710)
45. Chung S. W., Kang B. Y., Kim S. H., Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor- and nuclear factor- B The Journal of Biological Chemistry 2000 275 42 32681 32687
46. Kelly D., Campbell J. I., King T. P., Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shutting of PPAR- and ReIA Nature Immunology 2004 5 1 104 112 (Pubitemid 38081475)
47. Pascual G., Fong A. L., Ogawa S., A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR- Nature 2005 437 7059 759 763 (Pubitemid 41486547)
48. Jennewein C., Kuhn A. M., Schmidt M. V., Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines The Journal of Immunology 2008 181 8 5646 5652
49. Su C. G., Wen X., Bailey S. T., A novel therapy for colitis utilizing PPAR- ligands to inhibit the epithelial inflammatory response The Journal of Clinical Investigation 1999 104 4 383 389 (Pubitemid 29534322)
50. Marion-Letellier R., Butler M., Dchelotte P., Playford R. J., Ghosh S., Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cellspotential for dietary modulation of peroxisome proliferator-activated receptor in intestinal inflammation American Journal of Clinical Nutrition 2008 87 4 939 948
51. Ramakers J. D., Verstege M. I., Thuijls G., Te Velde A. A., Mensink R. P., Plat J., The PPAR agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis Journal of Clinical Immunology 2007 27 3 275 283 (Pubitemid 46790815)
52. Kato M., Kusumi T., Tsuchida S., Tanaka M., Sasaki M., Kudo H., Induction of differentiation and peroxisome proliferator-activated receptor expression in colon cancer cell lines by troglitazone Journal of Cancer Research and Clinical Oncology 2004 130 2 73 79 (Pubitemid 38316669)
53. Drori S., Girnun G. D., Tou L., Hic-5 regulates an epithelial program mediated by PPAR Genes Development 2005 19 3 362 375 (Pubitemid 40189299)
54. Lee C. J., Han J. S., Seo C. Y., Pioglitazone, a synthetic ligand for PPAR, induces apoptosis in RB-deficient human colorectal cancer cells Apoptosis 2006 11 3 401 411
55. Leung W. K., Bai A., Chan V. Y. W., Effect of peroxisome proliferator activated receptor ligands on growth and gene expression profiles of gastric cancer cells Gut 2004 53 3 331 338 (Pubitemid 38241325)
56. Cerbone A., Toaldo C., Laurora S., 4-Hydroxynonenal and PPAR ligands affect proliferation, differentiation, and apoptosis in colon cancer cells Free Radical Biology and Medicine 2007 42 11 1661 1670 (Pubitemid 46629012)
57. Lin M. S., Chen W. C., Bai X., Wang Y. D., Activation of peroxisome proliferator-activated receptor inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer Journal of Digestive Diseases 2007 8 2 82 88 (Pubitemid 46773619)
58. Chen G. G., Lee J. F., Wang S. H., Chan U. P. F., Ip P. C., Lau W. Y., Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and Nf- k B in human colon cancer Life Sciences 2002 70 22 2631 2646 (Pubitemid 34310556)
59. Duessel S., Heuertz R. M., Ezekiel U. R., Growth inhibition of human colon cancer cells by plant compounds Clinical Laboratory Science 2008 21 3 151 157
60. Baur J. A., Pearson K. J., Price N. L., Resveratrol improves health and survival of mice on a high-calorie diet Nature 2006 444 7117 337 342
61. Harari A., Harats D., Marko D., A 9- cis -carotene-enriched diet inhibits atherogenesis and fatty liver formation in LDL receptor knockout mice Journal of Nutrition 2008 138 10 1923 1930
62. Bachmeier B. E., Mohrenz I. V., Mirisola V., Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NF B Carcinogenesis 2008 29 4 779 789
63. Hatcher H., Planalp R., Cho J., Torti F. M., Torti S. V., Curcumin: from ancient medicine to current clinical trials Cellular and Molecular Life Sciences 2008 65 11 1631 1652
64. Jennings E., Folic acid as a cancer-preventing agent Medical Hypotheses 1995 45 3 297 303
65. Stone W. L., Krishnan K., Campbell S. E., Qui M., Whaley S. G., Yang H., Tocopherols and the treatment of colon cancer Annals of the New York Academy of Sciences 2004 1031 223 233 (Pubitemid 40361757)
66. Nieto N., Fernandez M. I., Torres M. I., Ros A., Suarez M. D., Gil A., Dietary monounsaturated n-3 and n-6 long-chain polyunsaturated fatty acids affect cellular antioxidant defense system in rats with experimental ulcerative colitis induced by trinitrobenzene sulfonic acid Digestive Diseases and Sciences 1998 43 12 2676 2687 (Pubitemid 29034922)
67. Pittas A. G., Harris S. S., Stark P. C., Dawson-Hughes B., The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults Diabetes Care 2007 30 4 980 986 (Pubitemid 46556596)
68. Chung I., Han G., Seshadri M., Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo Cancer Research 2009 69 3 967 975
69. Schatzkin A., Mouw T., Park Y., Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study American Journal of Clinical Nutrition 2007 85 5 1353 1360 (Pubitemid 46740479)
70. Lecona E., Barrasa J. I., Olmo N., Llorente B., Turnay J., Lizarbe M. A., Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase Molecular and Cellular Biology 2008 28 15 4665 4674
71. Guslandi M., Mezzi G., Sorghi M., Testoni P. A., Saccharomyces boulardii in maintenance treatment of Crohns disease Digestive Diseases and Sciences 2000 45 7 1462 1464 (Pubitemid 30636526)
72. Fotiadis C. I., Stoidis C. N., Spyropoulos B. G., Zografos E. D., Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer World Journal of Gastroenterology 2008 14 42 6453 6457
73. Roller M., Clune Y., Collins K., Rechkemmer G., Watzl B., Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients British Journal of Nutrition 2007 97 4 676 684 (Pubitemid 46470676)
74. Murakami A., Ashida H., Terao J., Multitargeted cancer prevention by quercetin Cancer Letters 2008 269 2 315 325
75. Bassaganya-Riera J., Reynolds K., Martino-Catt S., Activation of PPAR and by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease Gastroenterology 2004 127 3 777 791 (Pubitemid 39208411)
76. Wang C. Z., Xie J. T., Zhang B., Chemopreventive effects of Panax notoginseng and its major constituents on SW480 human colorectal cancer cells International Journal of Oncology 2007 31 5 1149 1156
77. Funk J. L., Frye J. B., Oyarzo J. N., Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis Arthritis and Rheumatism 2006 54 11 3452 3464
78. Cotterchio M., Boucher B. A., Manno M., Gallinger S., Okey A., Harper P., Dietary phytoestrogen intake is associated with reduced colorectal cancer risk Journal of Nutrition 2006 136 12 3046 3053
79. Slavin J. L., Mechanisms for the impact of whole grain foods on cancer risk Journal of the American College of Nutrition 2000 19 supplement 3 300S 307S (Pubitemid 30399585)
80. Yoshida T., Konishi M., Horinaka M., Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis Biochemical and Biophysical Research Communications 2008 375 1 129 133
81. Raza H., John A., In vitro effects of tea polyphenols on redox metabolism, oxidative stress, and apoptosis in PC12 cells Annals of the New York Academy of Sciences 2008 1138 358 365
82. Gordillo G., Fang H., Khanna S., Harper J., Phillips G., Sen C. K., Oral administration of blueberry inhibits angiogenic tumor growth and enhances survival of mice with endothelial cell neoplasm Antioxidants and Redox Signaling 2009 11 1 47 58
83. Edwards I. J., OFlaherty J. T., Omega-3 fatty acids and PPAR in cancer PPAR Research 2008 2008 14
84. Jakobsen C. H., Storvold G. L., Bremseth H., DHA induces ER stress and growth arrest in human colon cancer cells: associations with cholesterol and calcium homeostasis Journal of Lipid Research 2008 49 10 2089 2100
85. Berquin I. M., Edwards I. J., Chen Y. Q., Multi-targeted therapy of cancer by omega-3 fatty acids Cancer Letters 2008 269 2 363 377
86. Bassaganya-Riera J., Hontecillas R., CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD Clinical Nutrition 2006 25 3 454 465 (Pubitemid 43843028)
87. Campbell S., Stone W., Whaley S., Krishnan K., Development of gamma ()-tocopherol as a colorectal cancer chemopreventive agent Critical Reviews in Oncology/Hematology 2003 47 3 249 259 (Pubitemid 37072117)
88. Campbell S. E., Stone W. L., Whaley S. G., Qui M., Krishnan K., Gamma () tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma () expression in SW 480 human colon cancer cell lines BMC Cancer 2003 3, article 25 1 13 (Pubitemid 38851324)
89. Garcea G., Berry D. P., Jones D. J. L., Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences Cancer Epidemiology Biomarkers Prevention 2005 14 1 120 125 (Pubitemid 40165291)
90. Bliveau R., Gingras D., Role of nutrition in preventing cancer Canadian Family Physician 2007 53 11 1905 1911
91. Jackson S. M., Parhami F., Xi X.-P., Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 9 2094 2104 (Pubitemid 29422240)
92. Blanquicett C, Roman J, Hart C. M., Thiazolidinediones as anti-cancer agents Cancer Therapy 2008 6A 25 34